Childrens Mercy - Kansas City

In Ewing Sarcoma patients, exosomes in the blood may be an early detector of relapse. Partnering with the University of Kansas, Glenson Samuel, MD created a chip that could detect and analyze these exosomes and their proteins with minimum blood. Now, he is using that knowledge to find, and reverse, chemo-therapy-related resistance in tumor cells, making patients more responsive to therapy.Join Glenson Samuel, MD as he discusses his studies and his work with the genome center.